10-K/A

FORM 10-K AMENDMENT NO.1

Company: Sarepta Therapeutics, Inc.
Filed: May 2, 2011
Period of Report: December 31, 2010
Accession Number: 0001193125-11-121624

View Document ↗ View on SEC.gov ↗